PURE Bioscience Reports Fiscal Third Quarter 2013 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PURE Bioscience Reports Fiscal Third Quarter 2013 Results

SAN DIEGO, CA--(Marketwired - Jun 14, 2013) - PURE Bioscience, Inc. ( OTCQB : PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, reported results for its fiscal third quarter ended April 30, 2013.

Fiscal Q3 2013 Highlights

  • Initiated field testing of PURE® Hard Surface disinfectant with two major quick service restaurant chains, each with thousands of locations worldwide.
  • Completed a 30-day in-plant product testing process with a major meat and poultry food processor that manages multiple processing plants across the U.S.
  • Appointed food industry leader, Dave Pfanzelter, to the company's board of directors and subsequent to quarter-end appointed him chairman.

Fiscal Q3 2013 Results Net product sales totaled $258,000, compared to $207,000 in the same quarter last year. The increase was primarily attributable to increased sales to two existing customers.

Total operating costs and expenses decreased $200,000 to $1.8 million, compared to $2.0 million in the same year-ago quarter. The decrease was primarily due to a decrease in legal fees, travel, non-cash stock option expense, and depreciation and amortization expense.

Loss from operations decreased $200,000 to $1.6 million, compared to a loss from operations of $1.8 million in the same year-ago quarter.

Net loss was $1.5 million or $(0.14) per share, an improvement from a net loss of $1.8 million or $(0.31) per share in the same quarter last year.

As of April 30, 2013, cash and cash equivalents totaled $410,000 and current liabilities totaled $1.5 million, including accounts payable of $848,000. The company intends to secure additional working capital through sales of additional debt or equity securities.

Management Commentary "During the quarter, we significantly cut costs and streamlined our operations to improve our bottom line, while making progress with key sales opportunities that should position us for sustainable growth," said Michael L. Krall, president and CEO of PURE Bioscience. "Our sales and marketing projects during the quarter included coordinating field testing of PURE Hard Surface disinfectant and sanitizer in two different quick service restaurant chains, working with multiple meat and poultry food processors to conduct in-plant testing, and ongoing evaluations by several hospitals.

"Addressing the international opportunity, we recently shipped an opening order of PURE Hard Surface and PURE Multi-Purpose cleaner concentrate to our new European distributor, TICE. We are seeing progress with all of our target customer groups and remain optimistic that our marketing, education, evaluation and field testing programs could convert to meaningful sales in the second half of calendar 2013."

During the second half of 2013, the company intends to submit a notification of GRAS determination to the U.S. FDA for its review under the GRAS standards (Generally Recognized As Safe) for use of the SDC technology as a direct food contact antimicrobial (processing aid) and secondarily as a preservative (food additive). The additional GRAS claims for SDC are designed to expand its potential commercial adoption for direct use on produce and meats. The company has already obtained GRAS status for SDC when used on food processing facilities, equipment, machinery, and processing utensils. The FDA's stated goal is to respond within 180 days of the initial notification submission.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful.

About PURE Bioscience, Inc. PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA), Human Corona Virus and Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com .

Forward-Looking Statements This press release contains forward-looking statements in which the Company discusses its potential future performance. Forward-looking statements are all statements other than statements of historical facts, such as those statements regarding the Company's anticipated capital requirements, future financing activities, future submissions to the FDA related to its technologies and anticipated timing of commercialization of its technologies. The words "believe," "anticipate," "intend," "estimate," "project," "expect" and similar expressions are intended to identify those assertions as forward-looking statements. The Company cautions readers that forward-looking statements are not guarantees of future performance and its actual results may differ materially from those anticipated, projected or assumed in the forward-looking statements. Important factors that could cause the Company's actual results to differ materially from those anticipated in the forward-looking statements include, but are not limited to, the Company's cash position and liquidity requirements, the Company's failure to implement or otherwise achieve the benefits of its proposed initiatives and business plans, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks described in more detail under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended July 31, 2012, filed with the SEC, as updated by its subsequent filings with the SEC, including its Quarterly Reports on Form 10-Q. Investors are cautioned that many of the assumptions on which the Company's forward-looking statements are based are likely to change after its forward-looking statements are made. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

   
   
Pure Bioscience, Inc.  
Condensed Consolidated Balance Sheets  
         
  April 30,   July 31,  
  2013   2012  
  (Unaudited)      
Assets            
Current assets            
  Cash and cash equivalents $ 410,000   $ 877,000  
  Accounts receivable, net   29,000     373,000  
  Inventories, net   781,000     654,000  
  Prepaid expenses   110,000     347,000  
  Total current assets   1,330,000     2,251,000  
             
Property, plant and equipment, net   171,000     257,000  
Patents, net   2,004,000     1,950,000  
             
Total assets $ 3,505,000   $ 4,458,000  
             
Liabilities and stockholders' equity            
Current liabilities            
  Accounts payable $ 848,000   $ 1,946,000  
  Loan payable, net   -     962,000  
  Deferred revenue   -     66,000  
  Note payable, current   231,000     -  
  Accrued liabilities   411,000     344,000  
  Derivative liability   49,000     319,000  
  Total current liabilities   1,539,000     3,637,000  
             
Note payable, less current portion   1,045,000     -  
Deferred rent   15,000     3,000  
Total liabilities   2,599,000     3,640,000  
             
Commitments and contingencies            
             
Stockholders' equity            
  Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued   -     -  
  Common stock, $0.01 par value: 100,000,000 shares authorized 12,236,170 issued and outstanding at April 30, 2013, and 6,644,555 issued and outstanding at July 31, 2012.   123,000     67,000  
  Additional paid-in capital   68,795,000     63,251,000  
  Accumulated deficit   (68,012,000 )   (62,500,000 )
Total stockholders' equity   906,000     818,000  
             
Total liabilities and stockholders' equity $ 3,505,000   $ 4,458,000  
             
             
   
Pure Bioscience, Inc.  
Condensed Consolidated Statements of Operations  
(Unaudited)  
                         
    Nine months ended     Three months ended  
    April 30,     April 30,  
    2013     2012     2013     2012  
                                 
Net product sales   $ 631,000     $ 685,000     $ 258,000     $ 207,000  
                                 
Operating costs and expenses                                
  Cost of goods sold     155,000       206,000       67,000       37,000  
  Selling, general and administrative     4,550,000       5,439,000       1,464,000       1,557,000  
  Research and development     1,105,000       1,421,000       304,000       439,000  
Total operating costs and expenses     5,810,000       7,066,000       1,835,000       2,033,000  
                                 
Loss from operations     (5,179,000 )     (6,381,000 )     (1,577,000 )     (1,826,000 )
                                 
Other income (expense)                                
  Change in derivative liability     270,000       -       30,000       -  
  Interest expense     (591,000 )     -       (2,000 )     -  
  Interest income     -       1,000       -       -  
  Other (expense) income, net     (12,000 )     (3,000 )     15,000       (3,000 )
Total other (expense) income     (333,000 )     (2,000 )     43,000       (3,000 )
                                 
Net loss   $ (5,512,000 )   $ (6,383,000 )   $ (1,534,000 )   $ (1,829,000 )
                                 
Basic and diluted net loss per share   $ (0.53 )   $ (1.18 )   $ (0.14 )   $ (0.31 )
                                 
Shares used in computing basic and diluted net loss per share     10,310,721       5,400,685       11,255,833       5,838,466  
                                 
                                 

Investor Relations Contact: Ron Both Liolios Group, Inc. Tel 949-574-3860 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 110

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 88

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 72

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 43

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 33

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 13

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 98

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 98

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 438

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 72

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Eye Holiday Spending Surge with Retail ETFs

Updated Category News Views 230

Holiday Spending Trends Point to Retail ETF Gains As the festive season kicks off, investors are buzzing with anticipation. The projections indicate a remarkable surge in U.S. holiday sales, expected to hit between $1.01 trillion and $1.02 trillion. This optimism is driven by strong consumer demand, early sales promotions, and a decrease in inflation, setting a promising...

Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting

Updated Category News Views 263

Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...

Continue Reading
She Said Yes Launches Eco-Friendly Jewelry Initiative

Updated Category News Views 219

She Said Yes Empowers Customers with Tree-Planting Initiative She Said Yes, a renowned jewelry brand dedicated to using conflict-free diamonds and recycled gold, has unveiled an exciting partnership with WeForest to create a meaningful environmental initiative. This new program enables every jewelry purchase to contribute directly to global reforestation efforts,...

Continue Reading
Whale Traders Target Trump Media's Future with Options Movements

Updated Category News Views 121

Whale Traders Target Trump Media's Future with Options Movements Recently, investors with substantial capital have been showing strong interest in Trump Media & Technology (NASDAQ: DJT). This surge in activity is a signal that retail traders should pay attention to. Today, unusual trading patterns have been detected, hinting that significant financial players are...

Continue Reading
Partnership Boosts Digital Transformation in Japan's Life Sciences

Updated Category News Views 153

Transforming the Life Sciences Industry through Digital Solutions ValGenesis Inc. has teamed up with Hitachi Industry & Control Solutions, Ltd. to spearhead a transformative initiative aimed at elevating the capabilities of life sciences companies in Japan. This innovative partnership intends to bring forth cutting-edge digital validation solutions to streamline processes...

Continue Reading